Video Interview: TxCell Plans US Studies In Crohn's
Executive Summary
TxCell SA CEO Stéphane Boissel tells Sten Stovall why the French cell therapy company is exploring the therapeutic potential of regulatory T-cells (Tregs) in large-scale studies and extending its Phase IIb clinical study to the US using a recently granted IND.